MiNK Therapeutics, Inc.
Hedge Funds Holdings

Last updated:

MiNK Therapeutics, Inc.‘s stocks are currently a part of 9 hedge funds’ portfolios, which represents 1.55% of the total amount of its stocks outstanding. This makes up a total of 522.09K shares of MiNK Therapeutics, Inc.. Compared to the previous quarter, the number fell by -19.68% or -127.90K shares fewer. As for the holding position changes, 22.22% (2) of current hedge fund investors increased the number of shares held, 22.22% (2) of current holders sold a part of the shares held, and 33.33% (3) closed the holdings completely. 1 hedge funds are new holders of MiNK Therapeutics, Inc. stock in Q1 2023, it is 11.11% of total holders.

Hedge funds holding MiNK Therapeutics (Q4 2021 – Q1 2023)

Number of hedge funds
Q4 2021 21
Q1 2022 19
Q2 2022 7
Q3 2022 9
Q4 2022 17
Q1 2023 9

Hedge funds changes in MiNK Therapeutics positions (Q4 2021 – Q1 2023)

Changes in positions
Q4 2021 210000
Q1 2022 6658-6
Q2 2022 20313-11
Q3 2022 6104-2
Q4 2022 83204
Q1 2023 12231

Top 50 hedge fund holders of MiNK Therapeutics, Inc. (NASDAQ:INKT)

Hedge fund Value Shares owned Portfolio share
ARTAL GROUP S.A. 611K 289.58K 0.026%
FIRST REPUBLIC INVESTMENT MANAGEMENT, INC. 172K 81.5K 0.000%
VANGUARD GROUP INC 104K 49.10K 0.000%
GEODE CAPITAL MANAGEMENT, LLC 48K 23.17K 0.000%
STATE STREET CORP 23K 11.10K 0.000%
HIGHTOWER ADVISORS, LLC 22K 10.4K 0.000%
BLACKROCK INC. Larry Fink 21K 10.00K 0.000%
ROYAL BANK OF CANADA 1K 468 0.000%
UBS GROUP AG 1K 258 0.000%
FMR LLC 0 0 0.000%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 0 0 0.000%
MORGAN STANLEY 0 0 0.000%
TOWER RESEARCH CAPITAL LLC (TRC) 0 0 0.000%